CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
GRNQ
Greenpro Capital Corp.
There isn't enough reported data to score GRNQ yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
GRNQ Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
GRNQ's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | โ |
| Current | 24x | $605 | โ |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
GRNQ PE Valuation
GRNQ has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
GRNQ Forward outlook
There aren't enough analyst estimates for GRNQ to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over GRNQ on earnings quality, reporting a profit while its opponent remains loss making.
GRNQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.27 | -$1.67 |
| Q2 2026 | -$3.60 | -$2.30 |
| Q1 2026 | -$3.90 | -$2.60 |
| Q4 2025 | -$3.70 | -$2.80 |
| Q3 2025 | -$1.60 | +$6.90 |
| Q2 2025 | -$1.30 | +$7.00 |
| Q1 2025 | -$1.30 | -230% |
| Q4 2024 | -$0.90 | -164% |
GRNQ is still losing money, but far less than before: $3.27 per share over the past year, against $25.00 at its worst in late 2021.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over GRNQ on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over GRNQ on profitability, with a higher operating margin.
GRNQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $733.3K | +86% |
| Q2 2026 | $302.2K | -29% |
| Q1 2026 | $405.4K | +15% |
| Q4 2025 | $900.5K | -54% |
| Q3 2025 | $393.2K | -27% |
| Q2 2025 | $427.1K | +18% |
| Q1 2025 | $352.8K | -46% |
| Q4 2024 | $1.9M | +66% |
GRNQ's revenue is recovering but still below its 2024 peak: $733,325 last quarter, up 86% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -79% | +54 points |
| Q2 2026 | -243% | -102 points |
| Q1 2026 | -228% | -33 points |
| Q4 2025 | -38% | -68 points |
| Q3 2025 | -132% | -45 points |
| Q2 2025 | -141% | +26 points |
| Q1 2025 | -195% | -123 points |
| Q4 2024 | 30% | +92 points |
GRNQ's operating margin was โ79% last quarter, up 54 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with GRNQ at down 131%.
GRNQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$611.2K | -$442.6K |
| Q4 2024 | -$168.6K | +$212.7K |
| Q3 2024 | -$151.7K | +$47.2K |
| Q4 2023 | -$381.2K | -$135.1K |
| Q3 2023 | -$198.9K | +$593.6K |
| Q4 2022 | -$246.2K | -234% |
| Q3 2022 | -$792.5K | +$123.3K |
| Q2 2022 | -$589.7K | -$49K |
GRNQ has burned cash in almost every quarter: โ$5M over the past year, against โ$1M the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
GRNQ Net Leverage
GRNQ's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
GRNQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.6 | Neutral |
| Stochastic | 8.9 | Oversold |
GRNQ's weekly RSI is 39 (neutral) and its Stochastic is 9 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
GRNQ PE vs Industrials Sector
| Metric | GRNQ | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | โ |
GRNQ has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over GRNQ on trend strength, trading above more of its moving averages.
GRNQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.97 | 8% below |
| 20 week MA | $10.8 | 32% below |
| 50 week MA | $15.9 | 54% below |
| 100 week MA | $14.6 | 50% below |
| 200 week MA | $13.6 | 46% below |
GRNQ is in a downtrend: it's below all five of its weekly moving averages, and 46% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over GRNQ on returns for 2026, with the stronger performance.
GRNQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $63.0 | $128.0 | +103% |
| 2021 | $128.0 | $63.5 | -50% |
| 2022 | $63.5 | $10.8 | -83% |
| 2023 | $10.8 | $11.8 | +9.3% |
| 2024 | $11.8 | $10.6 | -10% |
| 2025 | $10.6 | $16.7 | +58% |
| 2026 YTD | $16.7 | $7.33 | -56% |
GRNQ's yearly returns have swung widely, from +103% in 2020 to โ83% in 2022. It's down 56% so far in 2026.